MDS Virtual Congress 2021 Archives - Page 65 of 132

Improvement of spasticity-related pain with incobotulinumtoxinA treatment in children/adolescents with cerebral palsy: pooled analysis of Phase 3 studies

F. Heinen, P. Kaňovský, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M. Banach, D. Gaebler-Spira (Munich, Germany)
Impulse Control Disorders Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial

T. Stiep, A. Ramirez-Zamora, A. Tröster, R. Jain, L. Chen, M. Okun (Gainesville, USA)
Impulse control disorders in idiopathic REM sleep behaviour disorder and drug-naive Parkinson’s disease

A. Otaiku (Birmingham, United Kingdom)
In vivo relationship between synaptic density and functional connectivity in progressive supranuclear palsy: a multimodal [11C]UCB-J PET and resting state fMRI study.

N. Holland, T. Rittman, T. Cope, A. Perry, S. Jones, G. Savulich, M. Malpetti, T. Fryer, F. Aigbirhio, J. O'Brien, J. Rowe (Cambridge, United Kingdom)
In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study

MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir (Seville, Spain)
Increased free-water in the substantia nigra in idiopathic REM sleep behaviour disorder

L. Zhou, G. Li, Y. Zhang, B. Li, H. Wei, J. Liu (Shanghai, China)
Increased non-motor impairment in Parkinson’s disease with REM-Sleep behaviour disorder; cross-sectional analysis in Luxembourg Parkinson’s Study

L. Pavelka, A. Rauschenberger, P. May, S. Pachchek, Z. Landoulsi, L. Pauly, D. Mcintyre, E. Glaab, R. Krüger (Belvaux, Luxembourg)
Increased prevalence of obsessive-compulsive symptoms in functional movement disorders

L. Novakova, J. Anyz, Z. Forejtová, M. Slovak, T. Rosikova, G. Vechetova, E. Ruzicka, T. Serranova (Prague, Czech Republic)
Increased stroke risk in Parkinson’s disease patients with LRRK2 mutations

D. Macias-Garcia, MT. Periñán, L. Muñoz-Delgado, S. Jesús, MV. Jimenez-Jaraba, D. Buiza-Rueda, M. Bonilla-Toribio, A. Adarmes-Gomez, F. Carrillo, P. Gómez-Garré, P. Mir (Seville, Spain)
Indirect Comparison of Apomorphine Sublingual Film Versus Levodopa Inhalation Powder for “OFF” Episodes in Parkinson’s Disease

A. Thach, M. Zichlin, N. Kirson, K. Yang, K. Gaburo, E. Pappert, D. Mehta, G. Williams (Marlborough, USA)